Xcene Research is a pioneering Contract Research Organization (CRO) based in Nigeria, with a focus on providing comprehensive support to pharmaceutical, biotechnology, and medical device companies, as well as academic institutions. The company specializes in the management, execution, and analysis of clinical trials, with a specific emphasis on a wide array of medical fields including vaccines, neglected tropical diseases, rare diseases, oncology, neurology, hematology, and cardiovascular and medical devices in Africa. Its services encompass the entire spectrum of clinical trial management, from Phase I through Phase IV, including multinational trials. Xcene Research also operates a site management organization, collaborating with other CROs on a global scale to handle a range of services from emerging products to post-marketing support. As a core value, the company emphasizes trust, ensuring on-time performance, top-notch quality, project transparency, and effective communication. With headquarters in Lagos, Nigeria, Xcene Research boasts extensive therapeutic experience, internal capacity, and financial stability to provide specialist services at competitive prices across a geographic region. The company's robust service portfolio includes site management, clinical trial monitoring, project management, patient recruitment, regulatory development, central laboratory services, clinical supplies, quality and compliance, medical and safety management, ECG services, consulting, and partnering. Since its establishment in 2015, Xcene Research has positioned itself as an influential player in the biotechnology, healthcare, and pharmaceutical industries, leveraging its niche expertise and strategic presence in Africa.
There is no investment information
No recent news or press coverage available for Xcene Research.